Protease-activated receptor-2 (PAR-2): Structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes

被引:48
|
作者
Maryanoff, BE [1 ]
Santulli, RJ [1 ]
McComsey, DF [1 ]
Hoekstra, WJ [1 ]
Hoey, K [1 ]
Smith, CE [1 ]
Addo, M [1 ]
Darrow, AL [1 ]
Andrade-Gordon, P [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Drug Discovery, Spring House, PA 19477 USA
关键词
protease-activated receptor; agonist peptides; intracellular calcium; structure-activity; tethered-ligand receptor; transfected cells;
D O I
10.1006/abbi.2000.2207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated receptor-a (PAR-S) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (-/-) cell line transfected with either human PAR-8 or PAR-1. A "directed" library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-8 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-S. The most potent agonist peptides (EC50 = 2-4 muM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05-0.35 muM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 muM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Re and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists. (C) 2001 Academic Press.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 30 条
  • [1] Cockroach allergen extract stimulates protease-activated receptor-2 (PAR-2) expressed in mouse lung fibroblast
    S. Kondo
    H. Helin
    M. Shichijo
    K. B. Bacon
    Inflammation Research, 2004, 53 : 489 - 496
  • [2] Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells
    Molino, M
    Raghunath, PN
    Kuo, A
    Ahuja, M
    Hoxie, JA
    Brass, LF
    Barnathan, ES
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) : 825 - 832
  • [3] Cockroach allergen extract stimulates protease-activated receptor-2 (PAR-2) expressed in mouse lung fibroblast
    Kondo, S
    Helin, H
    Shichijo, M
    Bacon, KB
    INFLAMMATION RESEARCH, 2004, 53 (09) : 489 - 496
  • [4] Fracture healing in protease-activated receptor-2 deficient mice
    O'Neill, Kevin R.
    Stutz, Christopher M.
    Mignemi, Nicholas A.
    Cole, Heather
    Murry, Matthew R.
    Nyman, Jeffry S.
    Hamm, Heidi
    Schoenecker, Jonathan G.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (08) : 1271 - 1276
  • [5] Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo
    Cheung, WM
    Andrade-Gordon, P
    Derian, CK
    Damiano, BP
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1998, 76 (01) : 16 - 25
  • [6] Protease-activated Receptor-2 (PAR-2)-mediated Nf-B Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma
    Johnson, Jeff J.
    Miller, Daniel L.
    Jiang, Rong
    Liu, Yueying
    Shi, Zonggao
    Tarwater, Laura
    Williams, Russell
    Balsara, Rashna
    Sauter, Edward R.
    Stack, M. Sharon
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (13) : 6936 - 6945
  • [7] Correlation of protease-activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis
    Alistair G. Tindell
    Elizabeth B. Kelso
    William R. Ferrell
    John C. Lockhart
    David A. Walsh
    Lynette Dunning
    Iain B. McInnes
    Rheumatology International, 2012, 32 : 3077 - 3086
  • [8] Clinical implication of protease-activated receptor-2 in idiopathic pulmonary fibrosis
    Park, Young Sik
    Park, Chang Min
    Lee, Hyun Ju
    Goo, Jin Mo
    Chung, Doo Hyun
    Lee, Sang-Min
    Yim, Jae-Joon
    Kim, Young Whan
    Han, Sung Koo
    Yoo, Chul-Gyu
    RESPIRATORY MEDICINE, 2013, 107 (02) : 256 - 262
  • [9] Protease-activated receptor-2 mediates proliferative responses in skeletal myoblasts
    Chinni, C
    de Niese, MR
    Jenkins, AL
    Pike, RN
    Bottomley, SP
    Mackie, EJ
    JOURNAL OF CELL SCIENCE, 2000, 113 (24) : 4427 - 4433
  • [10] Correlation of protease-activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis
    Tindell, Alistair G.
    Kelso, Elizabeth B.
    Ferrell, William R.
    Lockhart, John C.
    Walsh, David A.
    Dunning, Lynette
    McInnes, Iain B.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (10) : 3077 - 3086